Stop-MDA threshold checks
Is the survey below the WHO threshold?
A survey passes only if the upper end of the one-sided 95% exact confidence interval, not the observed prevalence, is below the threshold. Enter the survey counts; everything is calculated in your browser.
The planner finds the smallest sample whose upper 95% bound falls below the threshold if 0, 1 or 2 positives are found. Add a margin for refusals, losses and failed tests.
| Positives found | Children needed |
|---|
Transmission model · scenario explorer
How long must treatment continue?
Projections from a deterministic model that links human and Simulium populations with adult worms, skin microfilariae and the pharmacokinetics of ivermectin and moxidectin. Choose a transmission setting, coverage and up to five strategies.
Skin-snip microfilarial prevalence
% of the population, by years since the first round
Infective flies
Per 1,000 flies; dashed line is the WHO threshold (0.5 per 1,000)
Years of intervention needed
Elimination means skin-snip mf prevalence below 1% and infective flies below 1 in 2,000, both still met 20 years after all interventions stop.
| Strategy | Years needed | Flies below WHO threshold | mf prevalence below 1% |
|---|
Source: Mweya CN, Moxidectin, ivermectin and vector control for onchocerciasis elimination: a transmission model with within-host parasite and drug dynamics (under peer review). Strategies marked optimistic assume moxidectin kills 35% of adult worms per dose, which trials have not shown.
Elimination-readiness scorecard · template
How ready is a focus to stop treatment?
Ten criteria and one warning flag, each rated on the documented evidence with a grade for its quality. There is no total score: the criteria are not equally important, so each focus gets a profile and a stage. Your entries stay in this browser.
Tanzania
Onchocerciasis foci
Seven transmission foci, with the year community-directed treatment with ivermectin (CDTI) began. Focus-by-focus ratings will be added when the systematic review is published.
| Code | Focus | Districts (about 2012 boundaries) | CDTI start | Years by 2026 | Scorecard |
|---|
District lists are provisional and overstate the transmission area. Systematic review protocol: OSF 10.17605/OSF.IO/D2H83.
How it works
Three kinds of evidence, kept apart
Survey results, model projections and documented programme evidence answer different questions. The platform shows them side by side and never merges them into one number.
STEP 1
Survey results
Ov16 serology in children and O-150 PCR in flies are compared with the WHO thresholds using exact one-sided 95% bounds.
STEP 2
Transmission model
Human, fly, worm and drug dynamics, calibrated to clinical trial data and compared with elimination results from Mali and Senegal.
STEP 3
Readiness scorecard
Ten criteria rated on documented evidence, each with a quality grade: A peer-reviewed, B programme report, C indirect or modelled.
STEP 4
Expert decision
The national expert committee weighs all three. Model results enter only as grade C evidence.
Science and software
Sources
World Health Organization (2016). Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures. Geneva: WHO.
Mweya CN. Moxidectin, ivermectin and vector control for onchocerciasis elimination: a transmission model with within-host parasite and drug dynamics. Under peer review
Onchocerciasis elimination in Tanzania, focus by focus: a systematic review and elimination-readiness scorecard, 1995–2026. Protocol registered on OSF, 10.17605/OSF.IO/D2H83. In progress
Exact one-sided 95% bounds by the Clopper–Pearson method; fly prevalence from pool screening with equal pool sizes.
Open source. Platform software and model code are to be released under GPL-3.0-or-later.
Access and collaboration
Work with the platform
The calculators, scenarios and scorecard template are open to everyone. Programmes, researchers and students interested in focus-level analyses, validation or collaboration can write with the subject line “Oncho platform”.
mweya.clement@udsm.ac.tz